CORT: Corcept Therapeutics Incorporated

72.85 USD 0.67 (0.93%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

CORT exchange rate has changed by 0.93% for today. During the day, the instrument was traded at a low of 71.54 and at a high of 73.46.

Follow Corcept Therapeutics Incorporated dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

CORT News

Seeking Alpha 21:13 XPH: Healthcare Dashboard For July (NYSEARCA:XPH)
Zacks 14:17 Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Investing 12:18 Corcept submits new drug application for ovarian cancer treatment
Investing 14:34 Piper Sandler reiterates Overweight rating on Corcept Therapeutics stock
Seeking Alpha 20:33 ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
Investing 00:42 Corcept therapeutics officer Guyer sells $7350 in shares
Seeking Alpha 05:45 Beyond Cushing’s: The Undervalued Potential Of Corcept's Cortisol Modulators
Investing 13:17 Truist reiterates buy rating on Corcept stock, citing diabetes opportunity
Seeking Alpha 19:09 Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary
Investing 20:41 Cortisol modulator improves glucose control in diabetes patients
Seeking Alpha 17:24 IHE: Healthcare Dashboard For June (NYSEARCA:IHE)
Investing 21:06 Corcept reports annual meeting outcomes
Investing 17:14 Corcept May 2025 slides: Revenue target of $900-950M amid pipeline advances
Seeking Alpha 21:37 Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring
Investing 00:49 Corcept Therapeutics director Daniel Swisher sells $155k in stock
Seeking Alpha 08:51 American Century Small Cap Growth Fund Q1 2025 Commentary
Seeking Alpha 05:11 Tracking RenTech’s 13F Portfolio – Q1 2025 Update
Seeking Alpha 14:18 Harbor AlphaEdge Small Cap Earners ETF Q1 2025 Commentary (EBIT)
Benzinga 15:20 Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study - Corcept Therapeutics (NASDAQ:CORT)
Investing 10:12 Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
Investing 00:37 Corcept therapeutics officer Joseph Lyon sells shares worth $390,218
Seeking Alpha 12:00 abrdn U.S. Small Cap Equity Fund Q1 2025 Commentary
Investing 11:33 H.C. Wainwright reaffirms Corcept stock price target after study results
Seeking Alpha 06:36 Voya Small Company Fund Q1 2025 Commentary

Daily Range

71.54 73.46

Year Range

32.39 117.34

Previous Close: 71.41
Open: 72.18

Bid: 72.85
Ask: 73.15

Low: 71.54
High: 73.46

Volume: 1.530 K

Daily Change: 0.93%
Month Change: -0.61%

6 Months Change: 11.49%
Year Change: 88.39%

16 July, Wednesday